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Background. Mindfulness-based interventions have been shown to 
effectively reduce anxiety, depression and pain in patients with chronic 
physical illnesses. Objectives. We assessed the potential effectiveness and 
cost-effectiveness of a specially adapted Skype distant-delivered mindfulness 
intervention, designed to reduce distress for people affected by primary and 
secondary progressive MS. Methods. Forty participants were randomly 
assigned to the 8-week intervention (n=19) or a waiting-list control group 
(n=21). Participants completed standardised questionnaires to measure 
mood, impact of MS and symptom severity, quality of life and service costs at 
baseline, post-intervention and 3-month follow-up. Results. Distress scores 
were lower in the intervention group compared with the control group at post-
intervention and follow-up (p<0.05), effect size -.64 post-intervention and -.94 
at follow-up. Mean scores for pain, fatigue, anxiety, depression, impact of MS 
were reduced for the mindfulness group compared with control group at post-
therapy and follow-up; effect sizes ranging from -.27 to -.99 post-intervention 
and -.29 to -1.12 at follow-up. There were no differences in quality-adjusted 
life years, but an 87.4% probability that the intervention saves on service 
costs and improves outcome. Conclusions: A mindfulness intervention 
delivered through Skype video conferences appears accessible, feasible and 









Multiple sclerosis (MS) affects 2.3 million people worldwide [1], including 
127,000 people in the UK [2]. MS patients exhibit a higher prevalence of 
mood disorders relative to other medical [3] or neurological [4] conditions. 
Prevalence rates for depression and anxiety in MS are especially high [5]. 
These psychological sequelae may contribute to disease-related processes in 
MS [6]. Preliminary evidence suggests that reducing stress in MS results in 
reduction in new CNS lesions [7].  It therefore appears to be an important 
priority to make effective psychological therapies more readily available to 
people with MS.  
To date very few psychological therapies for MS have differentiated between 
patients with relapsing-remitting (RR) MS and those with a progressive MS 
type [8]. Further, most of the new MS treatments focus on RRMS [9]. We 
address this imbalance by piloting an intervention that was developed for and 
with the help of patients with secondary progressive (SP) and primary 
progressive (PP) MS.  
Mindfulness training can help people adjust to chronic illness [10]. Controlled 
trials on mindfulness in MS [11] showed that after the mindfulness training, 
patients reported improvements in quality of life, depression, fatigue [12, 13], 
standing and dynamic balance [13,14], and reduced fatigue and pain [15]. 
These results suggest that mindfulness is helpful in MS, but only one small 
study evaluated this methodology with patients with SPMS [14], two had small 
percentages (18%; 24%) of people with SPMS in their sample [12,13] and 




none looked at people affected by PPMS. Further, the previous trials excluded 
patients with more severe symptoms and limited mobility. In this study, we 
included all levels of disease severity and disability.  
The aims of this trial were: 
1.    To test trial processes to inform a phase III trial.  
2.    To evaluate the potential efficacy of the mindfulness intervention in terms 
of improvements in distress, depression, anxiety, impact of MS, pain and 
fatigue. 
3.    To assess the potential cost effectiveness of the mindfulness intervention. 
METHODS 
Study sample 
We used a parallel group randomised control design. We recruited 40 
participants across the UK. A pilot trial of at least 30 participants is adequate 
for obtaining estimates of the standard deviation of the outcome variable to 
determine sample size for an efficacy trial [16]. We recruited potential 
participants through adverts on the MS Society website and from National 
Health Service (NHS) MS centres across the UK.  
Recruitment took place between December 2012 and May 2013. We 
administered the screening questionnaires via telephone. Inclusion criteria 
were diagnosis of PPMS or SPMS, internet access and some level of distress 
determined by a score of 3 or greater on the General Health Questionnaire; 
GHQ-12 [17]. This cut-off score was chosen following recommendations for 




MS [18]. Exclusion criteria were severe cognitive impairment, as determined 
by a score of 20 or smaller on the Telephone Interview for Cognitive Status-
Modified; TICS-M [19] and high suicide risk, as assessed by a score of 20 or 
greater on the Clinical Outcome of Routine Evaluation; CORE-10 [20]. Finally, 
people were excluded if they reported any serious psychological disorders 
(e.g. psychosis, substance abuse), severe hearing impairment, attending 
other psychological therapies or prior formal training in mindfulness. 
Standard protocol approvals, registration and patient consents. 
The study was approved by London City Road and Hampstead Research 
Ethics Committee (12/LO/1394) and registered at the Current Controlled 
Trials database (ISRCTN93263909). All participants completed written 
informed consent. 
Randomisation  
Randomisation took place once a cohort of ten patients had been consented, 
screened and baseline data collected. An independent service at the King's 
College Mental Health and Neuroscience Clinical Trials Unit (CTU) handled 
the randomisation, using fixed block sizes of two. This method ensured the 
researchers could not influence the order of allocation, preserving pre-
randomisation allocation concealment. Each cohort of patients was 
randomised once the numbers recruited were sufficient to begin a group 
mindfulness course. On receiving the randomisation outcome from the CTU, 
AB notified participants of their group allocation.  Those in the mindfulness 
group were offered a date for their first session. Participants in the waiting-list 




group were discouraged from any new mindfulness related activities during 
the trial.  
Blinding 
The trial assessor (SW) was blind to treatment allocation. We used dummy 
codes in the data file, to ensure the statistician and health economists were 
blinded to treatment group allocation until they completed the main analyses. 
The nature of the intervention meant it was not feasible to keep the patients or 
clinical supervisors blind to treatment allocation. 
Mindfulness intervention  
The treatment phase took place between February 2013 and July 2013. We 
delivered the program in 8 hour-long sessions over an 8-week period via 
Skype video conferences. We restricted the number of participants up to 5 for 
each group based on Skype user guidance, which suggests the quality of 
videoconferences drops with more than this number [21].  Participants were 
sent a headset and webcam together with instructions of how to set up Skype.  
Participants could see each other and communicate as a group.   
The format and manual for the mindfulness group, including length of 
sessions and individual mindfulness practices, were developed in partnership 
with patients with MS through initial experimental case studies. The content of 
the manual was adapted from the Mindfulness-Based Cognitive Therapy 
(MBCT) course book [22]. MBCT includes most of the mindfulness based 
stress reduction (MBSR) syllabus with additional cognitive therapy exercises.  
We adapted these cognitive exercises so that instead of exploring how 




thoughts and feelings are linked and how this can lead to low mood, we 
discussed thoughts regarding having MS and how these thoughts are linked 
to anxiety and low mood. The eight chapters, one for each session, 
introduced key mindfulness concepts, addressed issues common to 
progressive MS, and described homework for the week ahead (see online 
supplementary material for content of each session). Each session started 
with a 10-minute mindfulness practice, followed by discussion of this practice 
and the homework practice of the previous week. Then new concepts (e.g. 
acceptance, relating to thoughts and self-compassion) were introduced. The 
mindfulness teacher asked open questions to facilitate a deeper 
understanding of the concepts. Formal teaching/psycho-education was kept to 
a minimum. A 5-10 minute mindfulness practice followed and finally 
homework for the next week was set. 
Feedback from people with progressive MS who took part in the series of 
experimental case-studies (n=6, EDSS range=6.5-7.5) emphasised that we 
needed to account for compromised concentration, fatigue, mobility and 
problems with sitting in one posture during mindfulness home practices. We 
consequently shortened the daily home practice to 10-20 minutes and 
provided audio CDs produced specifically for this course (details in the 
supplement). We also adapted the type of standard mindfulness practices by 
removing mindful movement practice to accommodate patients with little or no 
mobility. This decision was based on discussions with neurologists, MS 
nurses and 2 people with secondary progressive MS, who expressed their 
concern that the inclusion of mindful movement could make the course 
unattractive to people with severe mobility problems. Guidance in the CD 




practices reflected challenges of MS, such as lack of sensations or difficulties 
retaining a posture. Participants were encouraged to keep a diary of home 
practice, but, in fact, very few did record it.  
Teaching standards and teacher’s competence are important in mindfulness 
especially when working with vulnerable groups [23]. AB, a health 
psychologist, facilitated the courses. AB was supervised by PC, a clinical 
psychologist and expert mindfulness practitioner, who listened to session 
recordings to check fidelity of the intervention. AB and PC met weekly, and 
PC listened to excerpts of each and every session for supervision and fidelity 
purposes.  Prior to the study AB, completed a recognised mindfulness teacher 
training course and ran supervised pilot mindfulness groups and one-to-one 
courses for people with MS.  
Waiting-list / control 
Participants allocated to the waiting-list group received the treatment they 
would normally expect within the NHS. People may receive a mix of clinical 
input and review from both primary and secondary care providers, according 
to individual health needs. Few patients routinely receive treatment for 
distress, for example according to a survey conducted by the MS Society [24], 
two thirds of people agreed that ěThe NHS does not provide enough 
emotional support for MSĜ.  
Measurements 




Participants completed online questionnaires at baseline (prior to 
randomisation), post-intervention and 3-month follow-up. Assessments 
occurred between January 2013 and October 2013. The blind assessor (SW) 
notified participants by email when questionnaires were due.  Where 
participants had failed to complete the questionnaires a week later, SW 
phoned them to ensure that they had received the email and that they were 
not encountering any technical difficulties. Qualitative interviews (n=15) were 
conducted with people who took part in the mindfulness groups on their 
experiences of the intervention.  These will be reported in detail elsewhere. 
Demographics and MS data 
The baseline questionnaire included demographic information, such as 
ethnicity, age, gender, marital status, education and details about MS. The 
self-reported Expanded Disability Status Scale (EDSS) [25] was used to 
measure MS severity.  EDSS includes items on mobility, strength, co-
ordination, sensation, bladder, vision, speech, swallowing and cognition.  
EDSS scores can range from 0 (no neurological impairment) to 10 (death 
from MS).  
Primary outcome: 
The General Health Questionnaire, GHQ [17] is designed to measure general 
levels of distress. The GHQ is uncontaminated by the experience of MS-
related somatic symptoms and is the most treatment responsive measure of 
psychological distress in MS [26]. Higher scores on this scale represent high 
distress. 





Hospital Anxiety and Depression Scale; HADS [27]. This scale assesses the 
symptoms of anxiety and depression in both secondary and primary care 
patients [28]. Higher scores on this scale represent high anxiety and 
depression. 
Multiple Sclerosis Impact Scale; MSIS-29 [29]. MSIS-29 measures the 
physical, and the psychological impact of MS. MSIS-29 subscales have 
shown good variability, small floor and ceiling effects, high internal 
consistency and high test-retest reliability [29]. Higher scores on this scale 
represent high impact. 
Pain intensity was assessed with a numerical rating scale [30] (scaled from 0 
to 10) addressing the average pain, which is associated with MS according to 
the patient’s point of view. Thereby, 0 represents no pain and 10 the most 
painful sensation imaginable.  
Fatigue Severity Scale, FSS [31], assesses the impact of fatigue in the daily 
living of patients with three items related to physical impact, three items to the 
psychological environment and the remaining three are more generic. Higher 
scores on this scale represent high fatigue. 
Service use and costs were measured using an adapted version of the Client 
Service Receipt Inventory; CSRI [32]. This self-report measure recorded data 
on hospital, community health and social care services, and informal (unpaid) 
care from friends and relatives. The CSRI is always adapted for each study in 
which it is used. The format remains the same but the services included relate 




to the illness in question. Also, the CSRI period was chosen to cover the 
entire follow-up. 
EuroQol; EQ-5D [33] considers mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression and was used to generate Quality 
Adjusted Life Years, QALYs, [34], using the area-under-the-curve method.  
Data analysis plan 
Outcome analysis was conducted using Stata 12.1. To compare group 
demographic and clinical characteristics at baseline we used a binomial test 
for equal proportions between groups for categorical variables and an 
independent t-test for equal means between groups for continuous variables. 
We conducted all group comparisons on an intention-to-treat basis where we 
analysed participants in the group to which they were randomised. Treatment 
effects on the primary and secondary outcomes were estimated using linear 
mixed modelling where the outcome variables at the two post-intervention 
time points were the dependent variable. Baseline values of the outcome 
variable, time (post-intervention, follow-up), and group (mindfulness or 
waiting-list) were included as covariates. In addition, time*group interaction 
terms were included to allow treatment effects to vary across the post-therapy 
and 3-month follow-up assessments. Subject-varying random intercepts and 
slopes of time were included, in order to account for correlation between 
measures taken on the same individual at various time-points. We explored 
the effect of informative missingness processes by means of a formal 
sensitivity analysis [35]. Missing baseline covariates were handled using the 
missing indicator method [36]. This involves imputing missing values with the 




mean of the observed values and including variables for missingness for each 
variable with missing data in the model dummy. 
For the cost-effectiveness analysis, intervention costs were estimated using a 
bottom-up micro-costing approach of the resources and time spent by 
professionals providing the mindfulness sessions. Costs of other health and 
social care services used by participants were derived by multiplying the 
number of units (admission days, consultations, etc.) by their unit cost, taken 
from relevant publications [37]. Unit costs for the financial year 2012/13 were 
applied to individual services reported. 
We made cost comparisons between the two groups using bootstrapping 
methods to account for non-normality in the data distribution. Service cost 
data were combined with a change in the primary outcome measures (GHQ 
scores) and quality-adjusted life years (QALYs), generated from the EQ-5D to 
assess the cost-effectiveness. Incremental cost-effectiveness ratios were 
constructed. Uncertainty around these was explored using non-parametric 
bootstrapping with 1000 resamples to produce a joint distribution of 
incremental costs and effects for the two groups.  
RESULTS 
Sample selection and attrition 
The flow of participants through the trial is presented in Figure 1.  Of the 165 
information packs that were sent out to the recruitment sites across the UK, 
115 people expressed interest in participating, and 93 agreed to be assessed 
for eligibility.  Fifty were excluded, and three declined to be randomised.   




Insert Figure 1 here 
Of the 40 randomised participants, 17 (42%) had PPMS, and 23 (57.5%) had 
SPMS. The overall sample was 55% female, predominantly white British 
(90%), with a mean age of 52.7 years (SD=9.5), with the majority married or 
cohabiting (77.5%). Median time since diagnosis was 12.0 years (range=1- 
38).The mean neurological disability score (EDSS) was 6.5 (SD=1.5), which 
indicates a transition from being ambulant with an assistive device to requiring 
a wheelchair. Previous mindfulness studies in MS had all cut-off at EDSS 
score of 6 [11]. The groups were well matched for gender, age, marital status, 
education, EDSS scores, distress scores and time since diagnosis. However, 
the intervention group had fewer people with PPMS than the control group. 
We controlled for MS type in the intention-to-treat analysis to account for 
potential confounding due to the imbalance in MS type. The demographic and 
illness characteristics across the groups are presented in Table 1.  
Insert table 1 here 
Testing Trial Procedures  
Suitability of eligibility criteria  
Of the 50 people expressing interest in the study but excluded, 34 (68%) had 
GHQs below the requisite criteria, 3 (6%) had a high CORE score and 1 (2%) 
had a low TICS score. Twelve further individuals were ineligible for reasons 
including no access to a computer (8%), a diagnosis of RRMS (14%), and a 
hearing impairment (2%).     
Retention rates 




Eighteen of the 19 participants completed the mindfulness intervention. One 
participant dropped out after the first session due to changes in personal 
circumstances but continued to complete the study questionnaires. The 
remaining 18 participants continued participating in the mindfulness course 
until the end of the intervention. All the participants attended 4 or more of the 
8 mindfulness sessions and 14 (73.7%) attended 6 or more sessions. 
Reasons for not attending included: medical appointments, planned holidays, 
pain/ fatigue and technical problems, e.g. computer virus, stolen computer, 
problems with audio. In the waiting-list group, 2 participants (9.5%) at post-
intervention and 3 (14.3%) at 3-month follow-up failed to complete the 
questionnaire. In the mindfulness group, 2 participants (10.5%) did not 
complete the post-intervention questionnaires and 4 participants (21%) the 3-
month follow-up questionnaires.   
Potential Efficacy 
Primary outcome 
The mean and standard deviations at baseline, end of the intervention, and 3-
month follow-up for all outcomes are presented in Table 2. Table 3 provides 
the estimates for the treatment effect on the outcome variable in the original 
units of the scale (estimate column) and as a standardised effect size Cohen's 
d (effect size column). Mean GHQ scores were lower in the mindfulness 
group compared to waiting-list group at both the post-intervention and 3-
month follow-up. Both differences related to large effect sizes and were 
statistically significant at the 5% level. The effect size for post-intervention 




was -.64, a medium to large effect, and the 3-month effects size was -.94, a 
large effect. 
Descriptive statistics for primary, secondary and process 
outcomes 
Secondary outcomes 
Mean HADS depression, HADS anxiety, MSIS psychological and MSIS 
physical scores, pain and fatigue were reduced for the mindfulness group 
compared to waiting-list at both post-intervention and 3-month follow-up 
(Tables 2 and 3). For variables capturing psychological distress (HADS 
depression, HADS anxiety, and MSIS psychological) the magnitude of the 
difference tended to be medium to large and was significant for all at both 
post-intervention and 3-month follow-up, except anxiety post-therapy. Pain, 
fatigue and MSIS physical showed small to medium effect sizes, but these 
were non-significant, except for MSIS physical post-therapy and pain at three 
months. 
Insert tables 2 & 3 here 
Service use 
Both formal service and informal care costs were lower for the mindfulness 
group. Whilst hospital and social care costs were similar at baseline, by the 3-
month follow-up, the waiting-list group had substantially higher costs. This 
difference is explained by the high inpatient costs, which accounted for more 
than two-thirds of the health and social care cost for this group. However, this 
difference was not statistically significant (mean difference= -£720, 95% CI -




£2636 to £1196). Similarly, informal care costs were higher for the waiting-list 
group. It is worth noting that although the total costs were not particularly 
different at baseline (control group: £3703 versus mindfulness group: £3080), 
the difference had widened at 20-week follow-up, but was not statistically 
significant (mean difference -£2285, 95%CI -5003 to 579). 
QALYs accrued were greater in the waiting-list control group (see EQ5D 
Table 2), but this was largely due to a large baseline difference. When we 
control for baseline utility, the QALY difference is close to zero (-0.006, 95% 
CI -0.039 to 0.027). This, along with the cost savings for the mindfulness 
group, means that the latter has more than a 90% chance of being the most 
cost-effective option at a threshold of £20,000.  
Figure 2 is a scatterplot representing the bootstrapped societal costs-effects 
(GHQ) pairs for mindfulness compared to waiting-list (TAU). A great 
proportion (87.4%) of the scatter points lie in the south-east quadrant, 
showing that mindfulness is associated with lower costs, and better GHQ 
score, compared to the waiting-list group, therefore making it dominant. This 
indicates an 87.4% probability that the intervention saves money and 
improves outcomes. 
Insert Figure 2 here 
DISCUSSION 
The study suggests that a Skype delivered mindfulness intervention, adapted 
specifically for people with progressive MS, is feasible in terms of participants’ 
willingness to be screened for and enter a randomised controlled trial, and 




complete the intervention and assessments. The mindfulness intervention 
showed positive effects for people with progressive MS. Specifically, distress, 
as measured by GHQ, was lower in the mindfulness group compared to 
waiting-list group at the end of the intervention, and the effects remained at 
the 3-month follow-up. The effect size increased from a medium at the end of 
intervention to large effect at follow-up. Pain, fatigue, anxiety, depression and 
psychological and physical impact of MS were also reduced in the 
mindfulness group compared to waiting-list group both post-intervention and 
at 3-month follow-up.  The largest effects were for the mood variables.  
Our findings also indicate lower total costs (health, social and informal care) 
for the mindfulness group compared to the waiting-list group, but these 
differences were not statistically significant. For both groups, informal care 
costs contribute a considerably higher proportion to the total costs compared 
to health and social care, which is not unusual for MS patients [38].  Although 
the observed differences in costs QALYs are not statistically significant, the 
large cost differences and effects on outcome mean that there was a high 
probability that the intervention was cost-effective.  
There were no significant differences in QALY’s between the groups using 
EQ-5D. This could be attributed to the short follow-up period or the non-
responsiveness of the EQ-5D in people with progressive MS.  Three of the 
five items focus on physical abilities that are unlikely to change in progressive 
disease. Previous work indicates issues with all the five domains of the EQ-
5D [39].  The absence of questions related to cognition and fatigue which are 
often major issues in people with progressive MS have also been queried 
[40,41].  




Several previous trials of mindfulness interventions have shown benefits upon 
psychological well-being in people with chronic conditions [10]. This pilot trial 
looked specifically at reducing distress, anxiety and depression for people 
with progressive MS as very few psychological interventions have focused 
specifically on this group of patients with MS [9]. The shorter duration of each 
session and the daily homework practice meant that the mindfulness course 
might be more accessible and manageable to this group of patients. In fact, 
no dose response has been found between in-class hours and effect size [42] 
and shortened mindfulness practice has been successful before, for example 
in people with psychosis [43], anxiety, depression [44] and health-care staff 
[45].  
Further, traditional mindfulness programs all include mindful movement. We 
removed this practice based on feedback from people with progressive MS 
involved in the adaptation of the intervention and instead we used a general 
mindfulness practice that people could do when sitting.  This made sure our 
intervention was applicable even for people with severe mobility limitations. 
Our study also suggests that people with limited physical function can benefit 
from mindfulness practices, even without the mindful movement practice. 
However it is difficult to determine the actual effect of removing the mindful 
movement from the practices. According to a recent meta-analysis different 
meditation styles and traditions are characterized by different patterns of 
neural activation [46]. 
Limitations of this pilot study should be noted. First, mindfulness as a process 
was not measured. Observed benefits cannot be directly attributed to 
increased mindfulness. Second, there was no active control group; a full trial, 




with an active control, is needed to control for nonspecific therapy effects.  
Third, one mindfulness teacher delivered all the mindfulness courses.  Fourth, 
some participants questioned the adequacy for screening purposes (though 
not outcome assessment) of the GHQ response metric that asks respondents 
to compare their recent health with how it is ‘usually’. For many participants 
‘same as usual’ (scored 0) can mean experiencing high levels of distress, if 
this is seen as a long-term problem. Fifth, psychological outcome measures 
were based on patients self-report, and so these measures were dependent 
on participants’ willingness to report any difficulties. Finally, a larger trial can 
further examine the efficacy of the intervention. 
To conclude, this is the first study to show that delivering mindfulness to small 
groups via Skype is likely to be an effective treatment for distress in 
progressive MS. Further, a web-based training can be an accessible and 
flexible way to reach people across the country. The current study is the first 
to show that this adapted treatment approach is likely to be cost effective.  
The present study had a good recruitment rate, uptake and retention, 
suggesting a basis for further investigation in a larger scale study.   
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